CSIMarket
 


Dendreon Corp  (DNDN)
Other Ticker:  
 

Cumulative Dendreon's Quick Ratio for Trailing Twelve Months Period

DNDN's Quick Ratio for Trailing Twelve Months Period and Cash & cash equivalent, Current Liabilities growth


Select the Comparisons : Select the Ratio:

DNDN Quick Ratio for Trailing Twelve Months Period

(Sep 30 2014)
III. Quarter
(Jun 30 2014)
II. Quarter
(Mar 31 2014)
I. Quarter
(Dec 31 2013)
IV. Quarter
(Sep 30 2013)
III. Quarter
Y / Y Current Liabilities Growth -42.64 % -33.57 % 17.24 % -0.17 % 10.42 %
Y / Y Cash & cash equivalent Growth -35.87 % -38.63 % -43.62 % -49.23 % -57.3 %
Quick Ratio for Trailing Twelve Months Period 1.66 1.61 1.66 2.01 2.43
Total Ranking # 849 # 833 # 738 # 506 # 179
Seq. Current Liabilities Growth -13.77 % -27.5 % -2.08 % -6.31 % -0.13 %
Seq. Cash & cash equivalent Growth -16.05 % -17.95 % -13.62 % 7.79 % -19.66 %


Quick Ratio for Trailing Twelve Months Period Comment for 12 Months ending at Sep 30 2014
On the trailing twelve months basis Current Liabilities decreased faster than Dendreon's average Cash & cash equivalent, this led to increase in in Dendreon's Quick Ratio for Trailing Twelve Months Period to 1.66, Quick Ratio for Trailing Twelve Months Period remained below Dendreon Corp average.
Quick Ratio for Trailing Twelve Months Period is the average cumulative value over the last four quarters.

Among companies operatig within Biotechnology & Pharmaceuticals industry 26 other companies have achieved higher Quick Ratio for Trailing Twelve Months Period than Dendreon. While overall ranking remained unchanged compare to previous quarter at no. .

What is Quick Ratio?
Learn more about DNDN
Quick Ratio DNDN in the most recent quarter
Quick Ratio for Trailing Twelve Months Period Company Ranking
Within: No.
Industry # 27
Sector # 191
S&P 500 # 726


Quick Ratio for Trailing Twelve Months Period Statistics
High Average Low
4.37 2.65 1.61
(Dec 31 2012)   (Jun 30 2014)




Companies with similar average Quick Ratio for Trailing Twelve Months Period for 12 months ending Sep 30 2014, within Biotechnology & Pharmaceuticals Industry Quick Ratio for Trailing Twelve Months Period
Brainstorm Cell Therapeutics inc   4.43 
Palisade Bio Inc   4.15 
Nanostring Technologies Inc   3.80 
Seagen Inc   3.41 
Cel sci Corporation  3.37 
Amgen Inc   3.29 
Agenus Inc  3.20 
Halozyme Therapeutics Inc   3.19 
Vaxart Inc   3.17 
Viropharma Inc  3.00 
Protalix Biotherapeutics inc   2.99 
Ladrx Corporation  2.98 
Cellular Biomedicine Group Inc   2.96 
Telik Inc  2.85 
Biocryst Pharmaceuticals Inc   2.76 
Gentium S.p.a.  2.37 
Coherus Biosciences inc   2.20 
Mabvax Therapeutics Holdings, Inc.  2.04 
Exelixis Inc   1.95 
China Biologic Products Holdings Inc   1.77 
Cadence Pharmaceuticals Inc  1.75 
Dendreon Corp  1.65 
Eloxx Pharmaceuticals Inc   1.62 
Lineage Cell Therapeutics Inc   1.57 
Anavex Life Sciences Corp   1.52 
Vericel Corporation  1.51 
Qiagen N v   1.38 
Champions Oncology Inc   1.19 
Xstelos Holdings, Inc.  1.09 
Polarityte Inc   1.08 




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com